Stay updated with breaking news from Adapt Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The global saline nasal spray market is growing at a CAGR of 7.81% over the forecast period (2022 – 2030), owing to increased awareness of...
/PRNewswire/ -- The global saline nasal spray market is growing at a CAGR of 7.81% over the forecast period (2022 – 2030), owing to increased awareness of...
PUNE, India, March 8, 2022 /PRNewswire/ -- The global saline nasal spray market is growing at a CAGR of 7.81% over the forecast period (2022 - 2030), owing to increased awareness of nasal hygiene
An opinion was issued on Thursday from the United States Court of Appeals for the Federal Circuit. The appellants, Adapt Pharma, Inc. and related
Generic drug giant Teva scored a win at the Federal Circuit on Thursday when a divided panel stood by a New Jersey federal judge's invalidation of claims in four patents covering Adapt Pharma's opioid overdose medication Narcan.